SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-067647
Filing Date
2012-02-17
Accepted
2012-02-17 17:01:59
Documents
4
Period of Report
2012-02-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d303960d8k.htm 8-K 19471
2 PRESS RELEASE d303960dex991.htm EX-99.1 20788
3 GRAPHIC g303960g42u65.jpg GRAPHIC 3195
4 GRAPHIC g303960g98t56.jpg GRAPHIC 4115
  Complete submission text file 0001193125-12-067647.txt   51758
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 12623477
SIC: 2834 Pharmaceutical Preparations